CUV 2.87% $15.39 clinuvel pharmaceuticals limited

The increase in melanin certainly will have some direct effect...

  1. 20 Posts.
    lightbulb Created with Sketch. 2
    The increase in melanin certainly will have some direct effect but there’s a lot more going on than that I believe. Melanocortins have widespread effects and MT2 and Afamelanotide bind to different receptors although there’s definitely some overlap, probably on the receptors of most interest. I think a lot of the positive effects are from reduction in inflammation and upregulated DNA repair which I presume are independent of melanogenesis although not totally separated.

    The binding affinity and half-life I think are also quite different between the two molecules.

    This is why I don’t think it’s wise to compare what’s on the unregulated markets vs Clinuvel’s Afamelanotide. Don’t get me wrong though, in no way am I suggesting that I don’t think Afamelanotide is effective at reducing sunburn and skin cancer or provideing a host of other benefits.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.39
Change
0.430(2.87%)
Mkt cap ! $771.0M
Open High Low Value Volume
$14.96 $15.39 $14.83 $2.149M 141.3K

Buyers (Bids)

No. Vol. Price($)
1 590 $15.29
 

Sellers (Offers)

Price($) Vol. No.
$15.41 1079 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.